Opportunities to address the hepatitis C epidemic in the correctional setting
Opportunities to address the hepatitis C epidemic in the correctional setting
复制标题
DOI：
10.1086/427455
复制
发表时间：
2005-04-15
影响因子：
11.8
通讯作者：
Rich, JD
中科院分区：
文献类型：
--
作者：
Boutwell, AE;Allen, SA;Rich, JD
据估计，美国15%-40%的囚犯感染了丙型肝炎病毒(丙型肝炎病毒)。每年约有140万丙型肝炎病毒感染者通过惩教系统，占美国丙型肝炎病毒感染者总数的三分之一。丙型肝炎病毒感染的高流行率是由于过去20年与毒品有关的逮捕人数的大幅增加。尽管惩教系统中的丙型肝炎疫情可能被视为惩教卫生系统的负担，但它是一个重要的公共卫生机会和义务。在监禁者中实施具有成本效益的丙型肝炎病毒筛查、预防和治疗方案的研究至关重要。对囚犯进行检测、教育，并在适当情况下对囚犯进行治疗，应该是美国应对丙型肝炎疫情的公共卫生对策的基石。
An estimated 15%-40% of incarcerated persons in the United States are infected with hepatitis C virus (HCV). Approximately 1.4 million HCV-infected persons pass through the corrections system annually, accounting for one-third of the total number of HCV-infected persons in the United States. This high prevalence of HCV infection is due to the substantial increase in drug-related arrests over the past 2 decades. Although the hepatitis C epidemic in the corrections system may be viewed as a burden on correctional health systems, it is an important public health opportunity and an obligation. Research on the implementation of cost-effective HCV screening, prevention, and treatment programs among incarcerated persons is essential. Testing, education, and, when appropriate, treatment of prisoners should be a cornerstone of the public health response to the hepatitis C epidemic in the United States.